RESEARCH · US
Anthropic releases Claude Science, specialized model for pharmaceutical and biotech research
Anthropic unveiled Claude Science, a flagship model optimized for drug discovery, clinical analysis, and biotech workflows. Targets pharmaceutical/biotech researchers and executives.
WHY IT MATTERS
Signals Anthropic's vertical-market specialization strategy; BFSI fintech players (esp. healthcare-focused lending, insurtech) should test Claude Science for regulatory document analysis, claims processing.